Intellectual Property / Handling of Co-Development Findings Sample Clauses

Intellectual Property / Handling of Co-Development Findings. 5.1 During the Development Phase, INFLARX grants to BDB the non-exclusive, non transferrable right under the INFLARX Intellectual Property to research and develop IFX-x only as set forth under Article 2 and solely within the BDB Territory. BDB hereby accepts this grant. BDB's rights granted under this Section ‎5.1 shall be conditional to performance of any and all its obligations by BDB and subject to the terms and conditions set forth in this Addendum. 5.2 Subject to Section ‎5.1 above and subject to the provisions in Sections ‎3.2 and ‎3.3 above, all terms and conditions established within Sections ‎6.1 through ‎6.7 of the Co-Development Agreement with respect to BDB-2/IFX-2 and the corresponding BDB-2/IFX-2 Cell Line shall be fully applicable to BDB-x/IFX-x and its corresponding cell line/ manufacturing process. The Parties agree that the usage rights granted to BDB under Section ‎6.2 of the Co-Development Agreement and BDB’s right to be offered to pursue patent protection within the BDB Territory for any invention within the Co-Development Findings relating to the relevant Established IFX-x (and the respective BDB-x) as set forth on Section ‎6.4 ‎v. of the Co-Development Agreement shall be granted only and from the date of exercise of the option right by BDB with respect to the relevant Established IFX-x in accordance with Section ‎3.1 above. If and to the extent that BDB exercises its option right for any Established IFX-x, INFLARX shall from the date of execution of the option right by BDB in accordance with Section ‎3.1 not engage in any Commercialization either alone or together with or through a Third Party of any product containing any other independently developed molecule targeting the human complement factor C5a and the respective other target(s) to which the Established IFX-x and the respective BDB-x, for which BDB has exercised its option right, is binding within the BDB Territory. For the avoidance of doubt, INFLARX retains the right to develop and/or manufacture any other independently developed molecule targeting the human complement factor C5a and the respective other target(s) to which the Established IFX-x and the respective BDB-x, for which BDB has exercised its option right, is binding and any product containing such molecule inside the BDB Territory alone or together with or through a Third Party solely for the purpose of Exploitation and Commercialization of a product containing such molecule in the INFLARX Territory, and to Exploi...
View SourceView Similar (2)

Related to Intellectual Property / Handling of Co-Development Findings

  • Intellectual Property, etc Each of Holdings and each of its Subsidiaries owns or has the right to use all domestic and foreign patents, trademarks, permits, domain names, service marks, trade names, copyrights, licenses, franchises, inventions, trade secrets, proprietary information and know-how of any type, whether or not written (including, but not limited to, rights in computer programs and databases) and formulas, or other rights with respect to the foregoing, and has obtained assignments of all leases, licenses and other rights of whatever nature, in each case necessary for the conduct of its business, without any known conflict with the rights of others which, or the failure to obtain which, as the case may be, individually or in the aggregate, has had, or could reasonably be expected to have, a Material Adverse Effect.

  • Intellectual Property Matters A. Definitions

  • Intellectual Properties To the extent permissible under applicable law, all intellectual properties made or conceived by Employee during the term of this employment by Employer shall be the right and property solely of Employer, whether developed independently by Employee or jointly with others. The Employee will sign the Employer’s standard Employee Innovation, Proprietary Information and Confidentiality Agreement (“Confidentiality Agreement”).

  • Intellectual Property; Licenses, Etc The Borrower and its Subsidiaries own, or possess the right to use, all of the trademarks, service marks, trade names, copyrights, patents, patent rights, franchises, licenses and other intellectual property rights (collectively, “IP Rights”) that are reasonably necessary for the operation of their respective businesses, without conflict with the rights of any other Person. To the best knowledge of the Borrower, no slogan or other advertising device, product, process, method, substance, part or other material now employed, or now contemplated to be employed, by the Borrower or any Subsidiary infringes upon any rights held by any other Person. No claim or litigation regarding any of the foregoing is pending or, to the best knowledge of the Borrower, threatened, which, either individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect.

  • Intellectual Property Ownership We, our affiliates and our licensors will own all right, title and interest in and to all Products. You will be and remain the owner of all rights, title and interest in and to Customer Content. Each party will own and retain all rights in its trademarks, logos and other brand elements (collectively, “Trademarks”). To the extent a party grants any rights or licenses to its Trademarks to the other party in connection with this Agreement, the other party’s use of such Trademarks will be subject to the reasonable trademark guidelines provided in writing by the party that owns the Trademarks.